Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5598653 | 0.96 | LTA4H (0.30) | LTA4HTSHRCYP3A4TDP1 | |
| SCHEMBL1465968 | 0.87 | TDP1 (0.38) | LTA4HTSHRCYP3A4TDP1MAOB | |
| SCHEMBL195629 | 0.85 | LTA4H (0.43) | LTA4HTSHRCYP3A4TDP1CA4 | |
| SCHEMBL7615332 | 0.83 | LTA4H (0.41) | LTA4HTSHRCYP3A4TDP1CA4 | |
| SCHEMBL3628714 | 0.82 | LTA4H (0.33) | LTA4HTSHRCYP3A4TDP1MAOB | |
| SCHEMBL3628711 | 0.82 | LTA4H (0.33) | LTA4HTSHRCYP3A4TDP1MAOB | |
| SCHEMBL1466000 | 0.82 | LTA4H (0.33) | LTA4HTSHRCYP3A4TDP1MAOB | |
| SCHEMBL17189423 | 0.80 | CYP3A4 (0.43) | LTA4HTSHRCYP3A4TDP1CA4 | |
| SCHEMBL195903 | 0.80 | LTA4H (0.43) | LTA4HTSHRCYP3A4TDP1CA4 | |
| SCHEMBL28048701 | 0.79 | LTA4H (0.38) | LTA4HTSHRCYP3A4TDP1CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1437356-B1 | Copper complexes and the use thereof | LANXESS DEUTSCHLAND GMBH (DE) | 2006-03-29 | — | — | EP | claimed |
| US-20040198997-A1 | Copper complexes and their use | LANXESS DEUTSCHLAND GMBH (DE) | 2004-10-07 | — | — | US | claimed |
| US-7179946-B2 | Copper complexes and their use | LANXESS DEUTSCHLAND GMBH (DE) | 2007-02-20 | — | — | US | disclosed |
| US-6946577-B2 | Process for the production of aminodiphenylamines | BAYER AKTIENGESELLSCHAFT (DE) | 2005-09-20 | — | — | US | disclosed |
| US-20040198997-A1 | Copper complexes and their use | LANXESS DEUTSCHLAND GMBH (DE) | 2004-10-07 | — | — | US | disclosed |
| US-20040143139-A1 | Process for the production of aminodiphenylamines | LANXESS DEUTSCHLAND GMBH (DE) | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040143139-A1 | Process for the production of aminodiphenylamines | NUDT1, ITPA, NAAA | LTA4H 1050/4885TSHR 4313/4885CYP3A4 199/4885 |
| US-20040198997-A1 | Copper complexes and their use | SOD1, SOD3, ITPA | LTA4H 3598/4885TSHR 3515/4885CYP3A4 1213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.